Clearmind MedicineCMND
13F holders, Q1 2026 (March 31)5holders +2
3new positions
1sold out
$1.03avg. 13F price*
At the end of Q1 2026, 5 institutions reported holding Clearmind Medicine Inc. (CMND) in their 13F filings, up 2 from Q4 2025. 3 opened new positions and 1 sold out. The largest holders were XTX Topco Ltd ($23K), HRT Financial LP ($16K) and AdvisorShares Investments LLC ($8K).
- Company
- Clearmind Medicine Inc.
- CUSIP
- 185053501
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $39K |
| Exits | 1 | $9 |
All 13F filers, Q4 2025 → Q1 2026: 38,330 shares bought and 5 shares sold, net +38,325 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| XTX Topco Ltd | 0.00% | New | 21,694 | $23K |
| HRT Financial LP | 0.00% | New | 15,910 | $16K |
| AdvisorShares Investments LLC | 0.00% | Add +10.9% | 7,357 | $8K |
| UBS Group AG | 0.00% | New | 1 | $1 |
| Royal Bank of Canada | 0.00% | No change | 14 | $0 |
"% of holder's portfolio" is CMND's weight in each manager's 13F, not the share of Clearmind Medicine Inc. the manager owns.